1. Home
  2. PRDO vs HROW Comparison

PRDO vs HROW Comparison

Compare PRDO & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Perdoceo Education Corporation

PRDO

Perdoceo Education Corporation

SELL

Current Price

$31.86

Market Cap

2.0B

Sector

Real Estate

ML Signal

SELL

HROW

Harrow Inc.

BUY

Current Price

$30.32

Market Cap

1.7B

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
PRDO
HROW
Founded
1994
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.7B
IPO Year
1997
2008

Fundamental Metrics

Financial Performance
Metric
PRDO
HROW
Price
$31.86
$30.32
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
★ $65.00
AVG Volume (30 Days)
508.6K
★ 537.0K
Earning Date
11-03-2026
11-09-2026
Dividend Yield
★ 2.16%
N/A
EPS Growth
10.50
★ 71.43
EPS
★ 1.60
N/A
Revenue
★ $581,296,000.00
N/A
Revenue This Year
$0.99
$28.81
Revenue Next Year
$2.98
$53.97
P/E Ratio
$19.70
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$26.66
$28.54
52 Week High
$38.50
$54.98

Technical Indicators

Market Signals
Indicator
PRDO
HROW
Relative Strength Index (RSI) 48.07 25.71
Support Level $31.45 $28.54
Resistance Level $32.79 $35.43
Average True Range (ATR) 1.00 1.24
MACD -0.01 -0.18
Stochastic Oscillator 57.74 9.45

Price Performance

Historical Comparison
PRDO
HROW

About PRDO Perdoceo Education Corporation

Perdoceo Education Corp is an American for-profit education company that focuses on quality postsecondary education online to a diverse student population, along with campus-based and blended learning programs. The company's important segments include the American InterContinental University, the University of St. Augustine for Health Sciences, and Colorado Technical University. These universities provide undergraduate, graduate, and doctoral degree programs focusing on business, technology, management, and social services, with the majority of the students enrolled in programs offered fully online. The majority of the its revenue comes from the Colorado Technical University segment.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.

Share on Social Networks: